By far the largest fraction of the current molecular data on SR was generated indirectly by analyzing the emergence of mutated circulating tumor DNA (ctDNA) in the blood of CRC patients under anti-EGFR treatment. This evidence concerns the gene EGFR and colorectal carcinoma.